'김갑성' 기자의 전체기사
-
Henlius' Serplulimab (anti-PD-1 mAb) Granted Breakthrough Th…
[ 메디채널 김갑성 기자 ] The first CDE-designated Breakthrough Therapy for perioperative gastric cancer, promising accelerated patient access. The world's first gastric cancer perioperative regimen replacing chemotherapy with immunotherapy alone in the adjuvant setting has met primary endpoints in its phase 3 clinical trial, significantly reducing recurrence risk and improving cure rates. No immunotherapy has been approved globally for gastric cancer perioperative treatment – HANSIZHUANG is poised to address this unmet medical need. SHANGHAI, Nov. 20, 2025 -- Shanghai Henlius Biotech,
- 김갑성 기자
- 2025-11-20 18:52
-
Clarity Eye Centre Brings SILK™ Laser Eye Technology to Hon…
HONG KONG, Nov. 20, 2025 -- Clarity Eye Centre announced the arrival of Johnson & Johnson's next-generation SILK™ Laser Eye Technology, now available to patients in Hong Kong. The clinic is the first in the city to widely offer the ELITA™ Femtosecond Laser, the advanced system that powers SILK™ (Smooth Incision Lenticule Keratomileusis), ushering in a new era of precision and gentle laser vision correction for myopia, with or without astigmatism.[1] SILK™: A Revolutionary Leap in Refractive Surgery SILK™ represents a groundbreaking advancement in vision
- 김갑성 기자
- 2025-11-20 17:34
-
Gong Yingying: The Next Era of AI Healthcare Requires Trust…
KUALA LUMPUR, Malaysia, Nov. 20, 2025 -- At the 2025 Fortune Innovation Forum in Kuala Lumpur, global industry leaders and innovators gathered to explore the technologies transforming healthcare. Speaking at the featured roundtable "AI vs. MD," Ms. Gong Yingying, Founder and Chairwoman of Yidu Tech, shared her perspective on the responsible development of AI in healthcare. She was joined by KPJ Healthcare Berhad President & Managing Director Mr. Keat Chyuan Chin and NUHS Clinical Advisory Director Dr. Zubin Daruwalla, with Fortune AI Editor Jeremy Kahn moderating.
- 김갑성 기자
- 2025-11-20 16:52
-
KHB, MEDICA 2025에서 자동 화학발광 면역분석기 Polaris V150 선보여
[ 메디채널 김갑성 기자 ] 시안, 중국 2025년 11월 20일 -- 글로벌 체외진단(IVD) 솔루션 공급업체 상하이 케후아 바이오엔지니어링(Shanghai Kehua Bio-engineering Co., Ltd., KHB)이 세계적 의료 산업 전시회인 MEDICA 2025에서 최신 소형 화학발광 플랫폼 Polaris V150 자동 화학발광 면역분석기를 선보였다. 올해 KHB 부스의 핵심 전시 제품인 Polaris V150은 자동화 진단 분야에서 이룬 지속적인 혁신을 보여준다. 중소 규모 실험실은 물론 대형 병원과 외부 독립 검사기관의 STAT 및 응급 검사를 지원하도록 설계된 Polaris V150은 효율성과 정밀성, 사용 편의성을 하나의 탁상형 장비에 집약했다. 0.36m²의 설치 공간에 내장형 터치스크린과 컴팩트한 설계로 외부 장치 없이도 실험실에서 강력한 면역분석 기능을 제공한다. 작은 설치 공간과 효율적인 워크플로 0.36m²의 좁은 설치 면적에도 Polaris V150은 시간당 150건의 검사를 처리해 제한된 환경에서도 실험실이 효율적으로 운영될 수 있도록 한다. 시료•시
- 김갑성 기자
- 2025-11-20 15:23
-
Smartee Deepens Its Strategy for Central Asia and Russia in 2…
SHANGHAI, Nov. 20, 2025 -- Smartee Denti-Technology is reinforcing its international footprint with a focused strategy in Central Asia and Russia for 2025, cementing its position as a global leader in clear aligner and digital orthodontic technologies. This year, Smartee showcased its innovative orthodontic solutions at major regional exhibitions, including Dental Salon Moscow (April), Kazdent Expo Almaty and IDECA Tashkent (May), and Dental Expo Moscow and CADEX Almaty (September–October). These events underscored Smartee's expertise in digital orthodontics, highlighting its commitmen
- 김갑성 기자
- 2025-11-20 13:53
-
Remplir™ Nerve Sparing Prostate Cancer Surgery Commercial O…
Company to invest in further research to strengthen clinical evidence ahead of medium-term U.S. launch with no further FDA approvals needed Adoption of Remplir™ among Australian urologists is accelerating, with ~100 surgeries conducted by surgeons nationwide. This promising new application for Remplir can potentially reduce post-surgical complications from peripheral nerve injury, representing a globally significant commercial opportunity for the Company. Despite advances such as nerve-sparing techniques and robotic-assisted radical prostatectomy (RARP), damage to the peripheral
- 김갑성 기자
- 2025-11-20 13:52
-
Antengene Hosts 2025 R&D Day Showcasing Encouraging Clin…
SHANGHAI and HONG KONG, Nov. 20, 2025 -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, announced that at the R&D Day taking place today, it will present the latest data and future plans for three mid/late-stage clinical programs, including ATG-022 (CLDN18.2 antibody-drug conjugate [ADC]), ATG-037 (oral CD73 small mo
- 김갑성 기자
- 2025-11-20 10:56
-
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company…
[ 메디채널 김갑성 기자 ] WuXi AppTec sets new benchmarks in strategic execution and technological advancement, further strengthening its ability to support innovators worldwide as they deliver breakthrough medicines for patients. SAN ANTONIO, Nov. 20, 2025 -- Frost & Sullivan is pleased to announce that WuXi AppTec has received the 2025 Global Company of the Year Recognition in the contract research, development, and manufacturing organization (CRDMO) industry for its outstanding achievements in enabling innovation, operational excellence, and customer impact. This recognition underscores
- 김갑성 기자
- 2025-11-20 10:00
-
Dr James Liang Launches HK$500 Million "Genovation Found…
HONG KONG, Nov. 20, 2025 -- On World Children's Day, Dr James Liang, Co-founder of Trip.com Group, announced the establishment of the Genovation Foundation Limited in Hong Kong. Established in his personal capacity, the foundation pledges HK$500 million over five years to address declining fertility through three key avenues: economic subsidies, cultural advocacy, and policy research. The name Genovation combines "Gene" and "Innovation", symbolising both the continuity of life and the pursuit of creative solutions to pressing social challenges. This marks another si
- 김갑성 기자
- 2025-11-20 10:00
-
USANA Named No. 1 Dietary Supplements Brand in the Philippine…
Euromonitor Recognizes USANA Philippines as the Market Leader from 2019 to 2025 MANILA, Philippines, Nov. 20, 2025 -- USANA Health Sciences, Inc., a global leader in health and wellness, has once again been recognized as the No. 1 dietary supplements brand in the Philippines* by Euromonitor International—marking an unprecedented seven consecutive years at the top (2019–2025). This continued recognition underscores USANA's unwavering commitment to delivering science-based nutrition, premium-quality products, and exceptional trust among Filipino consumers. &
- 김갑성 기자
- 2025-11-20 09:16
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-11-20_THU
- Lanvin Group Holdings Limited to Hold Annual General Meeting on December 18, 2025 19:00
- MULTIPLE EVENTS L.L.C, a Subsidiary of AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C, Named Preferred Executive Service Partner for the 19th World Chinese Entrepreneurs Convention 19:00
- Henlius' Serplulimab (anti-PD-1 mAb) Granted Breakthrough Therapy Designation by China NMPA for Neo-/Adjuvant Treatment for Gastric Cancer 18:52
- HNWF2025 Leverages Common Roots to Grow ASEAN-Hainan FTP Collaboration 18:39
- Mondevo Group Unveils ITTIKAR: The World's First AI-Native Merchant Bank for Family Offices 18:09
- Suunto Elevates Your Black Friday Adventure with Unforgettable Deals on Watches and Gear 17:44
- Clarity Eye Centre Brings SILK™ Laser Eye Technology to Hong Kong 17:34
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 11월 20일 20시 40분